摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3-吡咯烷)丙酸 | 134448-22-9

中文名称
3-(3-吡咯烷)丙酸
中文别名
1H-吡咯-3-丙酸
英文名称
3-(1H-pyrrol-3-yl)propanoic acid
英文别名
——
3-(3-吡咯烷)丙酸化学式
CAS
134448-22-9
化学式
C7H9NO2
mdl
MFCD09800535
分子量
139.15
InChiKey
RJYXUUHRYSSIKQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    316.2±17.0 °C(Predicted)
  • 密度:
    1.245

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.285
  • 拓扑面积:
    53.1
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090

文献信息

  • [EN] HIGHLY SENSITIVE DETECTION OF BIOMOLECULES USING PROXIMITY INDUCED BIOORTHOGONAL REACTIONS<br/>[FR] DÉTECTION HAUTEMENT SENSIBLE DE BIOMOLÉCULES PAR DES RÉACTIONS BIOORTHOGONALES INDUITES PAR LA PROXIMITÉ
    申请人:UNIV CALIFORNIA
    公开号:WO2016109733A1
    公开(公告)日:2016-07-07
    There provided, inter alia, reagents and methods for modulation fluorescence of a tetrazine containing compound and/or a dienophile-containing compound. There is provided a method of detecting binding of a first affinity ligand and a second affinity ligand, the method includes the follow steps. Contacting a tetrazine-containing compound with a dienophile-containing compound, the tetrazine-containing compound comprising a first affinity ligand covalently attached to a tetrazine moiety and the dienophile-containing comprising a second affinity ligand covalently attached to a dienophile moiety.
    提供了用于调节含有四氮杂环的化合物和/或含有二烯丙基的化合物荧光的试剂和方法。提供了一种检测第一亲和配体和第二亲和配体结合的方法,该方法包括以下步骤。将含有四氮杂环的化合物与含有二烯丙基的化合物接触,其中含有四氮杂环的化合物包括与四氮杂环基团共价连接的第一亲和配体,含有二烯丙基的化合物包括与二烯丙基团共价连接的第二亲和配体
  • [EN] NEW COMPOUNDS HAVING A SELECTIVE PDE4D INHIBITING ACTIVITY<br/>[FR] NOUVEAUX COMPOSÉS PRÉSENTANT UNE ACTIVITÉ D'INHIBITION SÉLECTIVE VIS-À-VIS DE PDE4D
    申请人:UNIVERSIT DEGLI STUDI DI GENOVA
    公开号:WO2015121212A1
    公开(公告)日:2015-08-20
    Compounds of formula (I), wherein Z = cyclopentyl. cyclopropylmethyl, -CH3; R' = -CH3, CHF2, X= formula (II) (III) (IV) (V) Y = - CO; -C=O(CH2), -CH(OH)-CH2, -CH2-C=O, -CH2-CH2-C=O; -CH2-CH(OH)-CH2, -CH2- CH(OCOR1)-CH2 NR2 = -N(CH2-CH2OH)2, formula (VI) (VII) (VIII) (IX) (X) (XI) R1 = optionally substituted C1-C8 alkyl, optionally substituted aryl; optionally substituted aralkyl, preferably C1-C3 alkyl, more preferably CH3; and enantiomers, diastereoisomers and pharmaceutically acceptable salts thereof; these compounds have a PDE4D inhibiting activity and can be used as a medicament for treating dementia, in particular Alzheimer disease, and for improving memory.
    化合物的化学式(I),其中Z = 环戊基,环丙甲基,-CH3;R' = - ,CHF2,X = 化学式(II)(III)(IV)(V),Y = -CO;-C=O(CH2),-CH(OH)- ,- -C=O,- - -C=O;- -CH(OH)- ,- -CH(OCOR1)- ,NR2 = -N( - OH)2,化学式(VI)(VII)(VIII)(IX)(X)(XI),R1 = 可选择地取代的C1-C8烷基,可选择地取代的芳基;可选择地取代的芳基烷基,优选C1-C3烷基,更优选 ;以及其对映体,异构体和药学上可接受的盐;这些化合物具有PDE4D抑制活性,可用作治疗痴呆症,特别是阿尔茨海默病,并改善记忆的药物。
  • Tissue reactive compounds and compositions and uses thereof
    申请人:Angiotech International AG
    公开号:US20040219214A1
    公开(公告)日:2004-11-04
    A composition comprising a synthetic polymer, optionally in the presence of a drug, where the polymer comprises multiple activated groups. The multiple activated groups are reactive with functionality present on animal tissue, so that upon administration of the polymer to the tissue, the polymer binds to the tissue. Alternatively, the multiple activated groups are reactive with functionality present on a non-living surface, where the polymer binds to this surface to, e.g., increase the lubricity of the surface. When drug is present in the composition, the drug is then delivered to the site of polymer attachment.
    一种组合物包括一种合成聚合物,可选地存在药物,并且该聚合物包括多个活性基团。这些多个活性基团与动物组织上存在的功能性反应,因此在将聚合物注射到组织中时,聚合物与组织结合。或者,这些多个活性基团与非生物表面上存在的功能性反应,聚合物将与该表面结合,例如增加表面的润滑性。当组合物中存在药物时,药物将被传递到聚合物附着的部位。
  • Soft tissue implants and anti-scarring agents
    申请人:Hunter L. William
    公开号:US20050142162A1
    公开(公告)日:2005-06-30
    Soft tissue implants (e.g., breast, pectoral, chin, facial, lip, and nasal implants) are used in combination with an anti-scarring agent in order to inhibit scarring that may otherwise occur when the implant is placed within an animal.
    软组织植入物(例如乳房、胸肌、下巴、面部、唇部和鼻部植入物)与抗瘢痕剂结合使用,以抑制动物体内植入物放置时可能发生的瘢痕形成。
  • Hydroxy and amino functional pyrrolizidine catalyst compositions for the production of polyurethanes
    申请人:AIR PRODUCTS AND CHEMICALS, INC.
    公开号:EP0668303A1
    公开(公告)日:1995-08-23
    A method for preparing a polyurethane foam which comprises reacting an organic polyisocyanate and a polyol in the presence of a blowing agent, cell stabilizer and a catalyst composition consisting essentially of a pyrrolizidine of the formula: where R1 and R2 independently are -H, -OH, or-NR4R5, R3 is hydrogen, a C1-C1 2 alkyl, C5-C6 cycloalkyl, C6-C1 o aryl, or C7-C11 arylalkyl group, and R4 and R5 independently represent H, a C1-C12 alkyl group, C5-C10 cycloalkyl, C6-C10 aryl, or C7-C11 arylalkyl group, provided that at least R1 or R2 is not hydrogen.
    一种制备聚酯泡沫塑料的方法,包括使有机多异氰酸酯和多元醇在发泡剂、气室稳定剂和主要由式中吡咯烷组成的催化剂组合物存在下反应: 其中 R1 和 R2 分别为-H、-OH、 或-NR4R5、 R3 是氢、C1-C1 2 烷基、C5-C6 环烷基、C6-C1 o 芳基或 C7-C11 芳烷基,以及 R4 和 R5 独立地代表 H、C1-C12 烷基、C5-C10 环烷基、C6-C10 芳基或 C7-C11 芳烷基、 条件是至少 R1 或 R2 不是氢。
查看更多